Valuation : Jagsonpal Pharmaceuticals Limited

Market Cap 12.32B 129M 111M 104M 94.95M 179M 179M 1.23B 480M 6.21B 484M 474M 20.56B P/E 2024
32.7x
P/E 2025 26.4x
Enterprise Value 11.13B 117M 100M 93.64M 85.74M 162M 162M 1.11B 433M 5.61B 437M 428M 18.56B EV / Sales 2024
2.84x
EV / Sales 2025 4.92x
Free-Float
23.94%
Yield 2024
1.81%
Yield 2025 1.15%
1 day-2.15%
1 week+2.91%
Current month+2.68%
1 month+3.21%
3 months+14.00%
6 months+40.52%
Current year+23.04%
1 week 229.54
Extreme 229.54
248
1 month 217.18
Extreme 217.18
263.7
Current year 155
Extreme 155
264.5
1 year 155
Extreme 155
264.5
3 years 109.44
Extreme 109.44
328.04
5 years 49.2
Extreme 49.2
328.04
10 years 6.5
Extreme 6.5
328.04
Manager TitleAgeSince
Chief Executive Officer 59 16/07/2022
Director of Finance/CFO - 07/10/2025
Chief Operating Officer - 04/09/2025
Director TitleAgeSince
Chairman 69 04/12/2013
Chairman 54 16/07/2022
Director/Board Member - 29/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.15%+2.91%+1.34%+41.94% 167M
-0.49%-4.96%+61.09%+113.51% 1,060B
-1.50%-0.25%+50.85%+62.33% 651B
-1.83%-1.40%+24.08%+75.11% 465B
-1.17%-2.10%+38.61%+40.46% 365B
-2.00%-1.35%+22.22%+37.78% 300B
-0.98%+0.53%+2.04%+12.13% 258B
-0.20%+1.34%+52.64%+71.33% 238B
-3.18%-0.30%-17.23%-54.33% 210B
+0.08%+3.34%+30.12%+92.41% 184B
Average -1.29%-0.08%+26.58%+49.27% 373.06B
Weighted average by Cap. -1.13%-2.15%+38.81%+66.36%

Financials

2024 2025
Net sales 2.09B 21.85M 18.76M 17.56M 16.08M 30.29M 30.38M 208M 81.29M 1.05B 82.04M 80.27M 3.48B 2.69B 28.14M 24.15M 22.61M 20.7M 39M 39.11M 268M 105M 1.35B 106M 103M 4.48B
Net income 225M 2.35M 2.02M 1.89M 1.73M 3.26M 3.27M 22.38M 8.75M 113M 8.83M 8.64M 375M 554M 5.8M 4.98M 4.66M 4.27M 8.04M 8.06M 55.16M 21.56M 279M 21.76M 21.29M 923M
Net Debt -1.39B -14.55M -12.49M -11.7M -10.71M -20.17M -20.23M -138M -54.14M -701M -54.64M -53.46M -2.32B -1.19B -12.51M -10.74M -10.05M -9.21M -17.34M -17.39M -119M -46.54M -602M -46.97M -45.96M -1.99B
Logo Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
Employees
1,399
Date Price Change Volume
27/08/26 236.99 -2.15% 66,137
26/08/26 ₹242.20 +0.32% 76,102
25/08/26 ₹241.43 +0.27% 44,621
24/08/26 ₹240.77 +1.79% 219,001
21/08/26 ₹236.54 +1.52% 92,791
  1. Stock Market
  2. Stocks
  3. JAGSNPHARM Stock